Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AC Immune (ACIU) Accumulated Expenses: 2014-2025

Historic Accumulated Expenses for AC Immune (ACIU) over the last 12 years, with Sep 2025 value amounting to $15.0 million.

  • AC Immune's Accumulated Expenses rose 0.70% to $15.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $15.0 million, marking a year-over-year increase of 0.70%. This contributed to the annual value of $15.0 million for FY2025, which is N/A change from last year.
  • According to the latest figures from FY2025, AC Immune's Accumulated Expenses is $15.0 million, which was up 108,459.01% from $13,810 recorded in FY2024.
  • AC Immune's Accumulated Expenses' 5-year high stood at $18.3 million during FY2021, with a 5-year trough of $12,499 in FY2023.
  • Moreover, its 3-year median value for Accumulated Expenses was $13,810 (2024), whereas its average is $5.0 million.
  • Per our database at Business Quant, AC Immune's Accumulated Expenses skyrocketed by 49.37% in 2021 and then plummeted by 99.87% in 2023.
  • Over the past 5 years, AC Immune's Accumulated Expenses (Yearly) stood at $18.3 million in 2021, then plummeted by 46.63% to $9.8 million in 2022, then crashed by 99.87% to $12,499 in 2023, then rose by 10.49% to $13,810 in 2024, then reached $15.0 million in 2025.